Gilles Grateau Selected Research

Hereditary Autoinflammatory Diseases

1/2020	Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort.
2/2005	Amyloidosis and auto-inflammatory syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Grateau Research Topics

Disease

28	Amyloidosis 09/2022 - 03/2002
20	Inflammation (Inflammations) 12/2021 - 07/2002
15	Familial Mediterranean Fever (Periodic Disease) 05/2021 - 07/2002
7	Mevalonate Kinase Deficiency 12/2020 - 10/2004
6	Fever (Fevers) 04/2021 - 07/2002
6	Rheumatoid Arthritis 01/2019 - 03/2003
5	Cryopyrin-Associated Periodic Syndromes 11/2022 - 10/2004
5	Proteinuria 11/2022 - 12/2002
5	Renal Insufficiency (Renal Failure) 12/2020 - 07/2008
5	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020 - 08/2012
4	Infections 01/2022 - 01/2018
4	Necrosis 12/2021 - 07/2002
4	Immunoglobulin Light-chain Amyloidosis 11/2021 - 01/2006
4	Familial Amyloidosis (Hereditary Amyloidosis) 09/2014 - 03/2002
4	Amyloid Plaque 07/2011 - 03/2002
3	Acute-Phase Reaction 06/2021 - 02/2005
2	COVID-19 01/2022 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2021 - 04/2021
2	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2021 - 06/2012
2	Hereditary Autoinflammatory Diseases 01/2020 - 02/2005
2	Albuminuria 12/2017 - 05/2010
2	Abscess 06/2010 - 02/2008
1	Musculoskeletal Diseases (Musculoskeletal Disease) 07/2022
1	Gout 03/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	autosomal dominant familial Periodic fever 12/2021
1	Paraproteinemias (Monoclonal Gammopathy) 11/2021
1	Persistent Infection 06/2021
1	Reinfection 06/2021
1	Neoplasms (Cancer) 05/2021
1	Goiter 05/2021
1	Pain (Aches) 04/2021
1	Serositis 04/2021
1	Chediak-Higashi Syndrome 01/2021
1	Primary Immunodeficiency Diseases 01/2021
1	Chronic Granulomatous Disease 01/2021
1	Job Syndrome (Hyper-IgE Syndrome) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Disease Progression 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 01/2021
1	Fabry Disease (Fabry's Disease) 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Coinfection 01/2020
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2020
1	Acute Chest Syndrome 01/2020
1	Cryptogenic Cirrhosis 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Chronic Urticaria 01/2020
1	Hyponatremia 01/2020
1	Castleman Disease (Castleman's Disease) 12/2019

Drug/Important Bio-Agent (IBA)

24	AA amyloidosisIBA 11/2022 - 07/2002
14	Amyloid (Amyloid Fibrils)IBA 09/2022 - 10/2002
10	Proteins (Proteins, Gene)FDA Link 06/2021 - 03/2002
7	Interleukin-1 (Interleukin 1)IBA 11/2022 - 09/2009
6	Colchicine FDA LinkGeneric 04/2021 - 05/2012
6	Muramidase (Lysozyme)IBA 09/2014 - 03/2002
5	Prealbumin (Transthyretin)IBA 09/2022 - 03/2002
5	Biological ProductsIBA 01/2018 - 04/2009
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 04/2014
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 05/2012
4	Fibrinogen (Factor I)FDA Link 12/2017 - 03/2002
4	Amyloidogenic ProteinsIBA 01/2016 - 03/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2008
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 08/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 02/2008
3	InterleukinsIBA 05/2021 - 10/2019
3	CytokinesIBA 12/2020 - 09/2009
3	InflammasomesIBA 01/2020 - 01/2017
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2012 - 03/2002
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2007 - 10/2004
2	AutoantibodiesIBA 01/2020 - 02/2019
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2017 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 12/2007
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 10/2014 - 01/2006
2	fibrinogen AalphaIBA 04/2009 - 01/2006
2	Blood Proteins (Serum Proteins)IBA 07/2008 - 02/2005
1	AmyloseIBA 09/2022
1	VaccinesIBA 07/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Interleukin-6 InhibitorsIBA 12/2020
1	EnzymesIBA 01/2020
1	canakinumab FDA Link 01/2020
1	GlucansIBA 01/2020
1	SodiumIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2019
1	AdipokinesIBA 10/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2019

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2006
2	Length of Stay 01/2022 - 01/2020
2	Kidney Transplantation 12/2020 - 04/2009
2	Liver Transplantation 06/2012 - 04/2009
1	Thyroidectomy 05/2021
1	Renal Dialysis (Hemodialysis) 05/2021
1	Biological Therapy 12/2020
1	Erythrocyte Transfusion 01/2020